Best way to revascularize patients with main stem and three vessel lesions: Patients should undergo PCI!

Clinical Research in Cardiology

Volumn 99, Issue 9, 2010, Pages 531-539

  Schächinger, Volker ^a   Herdeg, Christian ^b   Scheller, Bruno ^c  

^a KLINIKUM FULDA   (Germany)

^b Paracelsus Krankenhaus Ruit   (Germany)

^c NONE

Author keywords

Coronary artery bypass grafting; Left main stenosis; Multi vessel disease; Percutaneous coronary intervention

Indexed keywords

EVEROLIMUS;

ACUTE CORONARY SYNDROME; BARE METAL STENT; CARDIOVASCULAR RISK; CLINICAL PRACTICE; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY RECANALIZATION; DIABETES MELLITUS; DRUG ELUTING STENT; HEART INFARCTION; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MORTALITY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; QUALITY OF LIFE; REVIEW; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STABLE ANGINA PECTORIS; STROKE;

ANGIOPLASTY, BALLOON, CORONARY; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 77958021395     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-010-0189-8     Document Type: Review

References (42)

1. Kereiakes DJ, Teirstein PS, Sarembock IJ, Holmes DR Jr, Krucoff MW, O'Neill WW, Waksman R, Williams DO, Popma JJ, Buchbinder M, Mehran R, Meredith IT, Moses JW, Stone GW (2007) The truth and consequences of the COURAGE trial. J Am Coll Cardiol 50:1598-1603
2. van Buuren F, Horstkotte D (2009) 24 Bericht über die Leistungszahlen der Herzkatheterlabore in der Bundesrepublik Deutschland. Kardiologe 3:512-518
3. Gummert JF, Funkat A, Beckmann A, Schiller W, Hekmat K, Ernst M, Haverich A (2009) Cardiac surgery in Germany during 2008. A report on behalf of the German Society for Thoracic and Cardiovascular Surgery. Thorac Cardiovasc Surg 57:315-323
4. German quality insurance registry (2009). http://www.bqsonline.de
5. Mehta SR, Granger CB, Boden WE, Steg PG, Bassand JP, Faxon DP, Afzal R, Chrolavicius S, Jolly SS, Widimsky P, Avezum A, Rupprecht HJ, Zhu J, Col J, Natarajan MK, Horsman C, Fox KA, Yusuf S, TIMACS Investigators (2009) Early versus delayed invasive intervention in acute coronary syndromes. N Engl J Med 360 (21):2165-2175
6. de Winter RJ, Windhausen F, Cornel JH, Dunselman PH, Janus CL, Bendermacher PE, Michels HR, Sanders GT, Tijssen JG, Verheugt FW (2005) Early invasive versus selectively invasive management for acute coronary syndromes. N Engl J Med 353:1095-1104 (Pubitemid 41317432)
7. Alexiou K, Kappert U, Staroske A, Joskowiak D, Wilbring M, Matschke K, Tugtekin SM (2008) Coronary surgery for acute coronary syndrome: which determinants of outcome remain? Clin Res Cardiol 97 (9):601-608
8. Van de Werf F, Bax J, Betriu A, Blomstrom-Lundqvist C, Crea F, Falk V, Filippatos G, Fox K, Huber K, Kastrati A, Rosengren A, Steg PG, Tubaro M, Verheugt F, Weidinger F, Weis M, Vahanian A, Camm J, De CR, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Silber S, Aguirre FV, Al-Attar N, Alegria E, Andreotti F, Benzer W, Breithardt O, Danchin N, Di MC, Dudek D, Gulba D, Halvorsen S, Kaufmann P, Kornowski R, Lip GY, Rutten F (2008) Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the task force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology. Eur Heart J 29:2909-2945
9. Keeley EC, Boura JA, Grines CL (2003) Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 361:13-20
10. Scheller B, Hennen B, Hammer B, Walle J, Hofer C, Hilpert V, Winter H, Nickenig G, Böhm M, for the SIAM III study group (2003) Beneficial effects of immediate stenting after thrombolysis in acute myocardial infarction. J Am Coll Cardiol 42:634-641
11. Cantor WJ, Fitchett D, Borgundvaag B, Ducas J, Heffernan M, Cohen EA, Morrison LJ, Langer A, Dzavik V, Mehta SR, Lazzam C, Schwartz B, Casanova A, Goodman SG (2009) TRANSFER-AMI Trial Investigators. Routine early angioplasty after fibrinolysis for acute myocardial infarction. N Engl J Med 360 (26):2705-2708
12. Pfisterer M (2004) Long-term outcome in elderly patients with chronic angina managed invasively versus by optimized medical therapy: four-year follow-up of the randomized trial of invasive versus medical therapy in elderly patients (TIME). Circulation 110:1213-1218 (Pubitemid 39202335)
13. Davies RF, Goldberg AD, Forman S, Pepine CJ, Knatterud GL, Geller N, Sopko G, Pratt C, Deanfield J, Conti CR (1997) Asymptomatic Cardiac Ischemia Pilot (ACIP) study two-year follow-up: outcomes of patients randomized to initial strategies of medical therapy versus revascularization. Circulation 95:2037-2043
14. Shaw LJ, Berman DS, Maron DJ, Mancini GB, Hayes SW, Hartigan PM, Weintraub WS, O'Rourke RA, Dada M, Spertus JA, Chaitman BR, Friedman J, Slomka P, Heller GV, Germano G, Gosselin G, Berger P, Kostuk WJ, Schwartz RG, Knudtson M, Veledar E, Bates ER, McCallister B, Teo KK, Boden WE (2008) Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Circulation 117:1283-1291
15. Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS (2003) Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation 107:2900-2907
16. Katritsis DG, Ioannidis JP (2005) Percutaneous coronary intervention versus conservative therapy in nonacute coronary artery disease: a meta-analysis. Circulation 111:2906-2912
17. Takaro T, Hultgren HN, Lipton MJ, Detre KM (1976) The VA cooperative randomized study of surgery for coronary arterial occlusive disease II: subgroup with significant left main lesions. Circulation 54 (suppl III): III-107-III-117
18. Yusuf S, Zucker D, Peduzzi P, Fisher LD, Takaro T, Kennedy JW et al (1994) Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet 344:563-570
19. Hueb W, Lopes NH, Gersh BJ, Soares P, Machado LA, Jatene FB, Oliveira SA, Ramires JA (2007) Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation 115 (9):1082-1089
20. Bravata DM, Gienger AL, McDonald KM, Sundaram V, Perez MV, Varghese R, Kapoor JR, Ardehali R, Owens DK, Hlatky MA (2007) Systematic review: the comparative effectiveness of percutaneous coronary interventions and coronary artery bypass graft surgery. Ann Intern Med 147:703-716
21. Hlatky MA, Boothroyd DB, Bravata DM, Boersma E, Booth J, Brooks MM, Carrié D, Clayton TC, Danchin N, Flather M, Hamm CW, Hueb WA, Kähler J, Kelsey SF, King SB, Kosinski AS, Lopes N, McDonald KM, Rodriguez A, Serruys P, Sigwart U, Stables RH, Owens DK, Pocock SJ (2009) Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials. Lancet 373:1190-1197
22. Kereiakes DJ, Faxon DP (2006) Left main coronary revascularization at the crossroads. Circulation 113 (21):2480-2484
23. Moses JW, Leon MB, Stone GW (2009) Left main percutaneous coronary intervention crossing the threshold: time for a guidelines revision!. J Am Coll Cardiol 54 (16):1512-1514
24. Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ, Stahle E, Feldman TE, van den Brand M, Bass EJ, Van DN, Leadley K, Dawkins KD, Mohr FW (2009) Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 360:961-972
25. Feldman TE, for the SYNTAX investigators (2009) Analysis of outcome after repeat revascularization: analysis from the SYNTAX trial. Presented at TCT 2009
26. Meier B (2000) Coronary angioplasty is like going to the dentist. Heart 83:491-492
27. Newman MF, Kirchner JL, Phillips-Bute B, Gaver V, Grocott H, Jones RH, Mark DB, Reves JG, Blumenthal JA (2001) Longitudinal assessment of neurocognitive function after coronaryartery bypass surgery. N Engl J Med 344:395-402
28. Kappetein AP, for the SYNTAX investigators (2009) Optimal revascularization strategy in patients with three-vessel disease and/or left main disease: the 2-year outcome of the SYNTAX trial. Presented at ESC 2009
29. Daemen J, Boersma E, Flather M, Booth J, Stables R, Rodriguez A, Rodriguez-Granillo G, Hueb WA, Lemos PA, Serruys PW (2008) Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease: a meta-analysis with 5-year patient-level data from the ARTS, ERACI-II, MASS-II, and SoS trials. Circulation 118:1146-1154
30. Serruys PW, Onuma Y, Garg S, Vranckx P, De Bruyne B, Morice MC, Colombo A, Macaya C, Richardt G, Fajadet J, Hamm C, Schuijer M, Rademaker T, Wittebols K, Stoll HP, ARTS II Investigators (2010) 5-Year clinical outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the sirolimuseluting stent in the treatment of patients with multivessel de novo coronary artery lesions. J Am Coll Cardiol (epub ahead of print)
31. Hannan EL, Wu C, Walford G, Culliford AT, Gold JP, Smith CR, Higgins RS, Carlson RE, Jones RH (2008) Drug-eluting stents vs coronary-artery bypass grafting in multivessel coronary disease. N Engl J Med 358:331-341
32. Ong AT, Serruys PW, Mohr FW, Morice MC, Kappetein AP, Holmes DR Jr, Mack MJ, van den Brand M, Morel MA, van Es GA, Kleijne J, Koglin J, Russell ME (2006) The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: design, rationale, and run-in phase. Am Heart J 151:1194-1204
33. Sianos G, Morel M-A, Kappetein AP, Morice MC, Colombo A, Dawkins K, van den Brand M, van Dyck N, Russel, Russell ME, Mohr FW, Serruys PW (2005) The SYNTAX score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention 1:219-227
34. Silber S, Albertsson P, Aviles FF, Camici PG, Colombo A, Hamm C, Jorgensen E, Marco J, Nordrehaug JE, Ruzyllo W, Urban P, Stone GW, Wijns W (2005) Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J 26:804-847
35. Serruys PW, Mohr FW, for the SYNTAX investigators (2008) SYNTAX trial: primary endpoint results at one year in subset of patients with left main disease. Presented at TCT 2008
36. Serruys PW, Mohr FW, Onuma Y, for the SYNTAX investigators (2008) SYNTAX trial: approach to the patient with multivessel and/or left main disease: interventional perspectives. Presented at TCT 2008
37. Mohr FW, Serruys PW, for the SYNTAX investigators (2008) SYNTAX trial: Multivessel disease stratification. Presented at TCT 2008
38. Banning AP, Westaby S, Morice MC, Kappetein AP, Mohr FW, Berti S, Glauber M, Kellett MA, Kramer RS, Leadley K, Dawkins KD, Serruys PW (2010) Diabetic and nondiabetic patients with left main and/or 3-vessel coronary artery disease. Comparison of outcomes with cardiac surgery and paclitaxeleluting stents. J Am Coll Cardiol (epub ahead of print)
39. Mohr FW, Serruys PW, for the SYNTAX investigators (2009) SYNTAX trial: one year result of the PCI and CABG registries. Presented at ESC 2009
40. Stone GW, Midei M, Newman W, Sanz M, Hermiller JB, Williams J, Farhat N, Caputo R, Xenopoulos N, Applegate R, Gordon P, White RM, Sudhir K, Cutlip DE, Petersen JL (2009) Randomized comparison of everolimus-eluting and paclitaxeleluting stents: two-year clinical follow-up from the clinical evaluation of the Xience V everolimus eluting coronary stent system in the treatment of patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial. Circulation 119:680-686
41. Hong MK, Mintz GS, Lee CW, Park DW, Choi BR, Park KH, Kim YH, Cheong SS, Song JK, Kim JJ, Park SW, Park SJ (2006) Intravascular ultrasound predictors of angiographic restenosis after sirolimus-eluting stent implantation. Eur Heart J 27:1305-1310
42. Tonino PA, de BB, Pijls NH, Siebert U, Ikeno F, Veer M, Klauss V, Manoharan G, Engstrom T, Oldroyd KG, Ver Lee PN, MacCarthy PA, Fearon WF (2009) Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med 360:213-224